Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Tesetaxel Administered in Combination With Capecitabine to Subjects With Solid Tumors

NCT01315431 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT01315431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01315431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Tesetaxel Administered in Combination With Capecitabine to Subjects With Solid Tumors
Lead sponsor
Genta Incorporated
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2011
Completion date
October 31, 2012
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor